Hackensack Meridian Health

Hackensack, New Jersey 07601

10 studies enrolling now · 35 studies all time

What they study most

Acute Myocardial Infarction (AMI), Acute Respiratory Distress Syndrome, Adult, Advanced Solid Tumor, Aggressive B-cell Non-Hodgkin Lymphoma (aNHL), Atrial Fibrillation, Borderline Resectable Pancreatic Cancer, Breast Cancer, C3 Glomerulonephritis, C3 Glomerulopathy, C3G, Calcific Aortic Valve Disease, Cancer

Studies at this site

• Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers — Recruiting now
• A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer — Recruiting now
• Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease — Recruiting now
• Pancreatic Cancer Early Detection Consortium — Recruiting now
• Combination Therapy for the Treatment of Diffuse Midline Gliomas — Recruiting now
• Clinical Trial of Approaches to Prostate Cancer Surgery — Recruiting now
• ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack — Recruiting now
• The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation — Recruiting now
• A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer — Recruiting now
• Cardiogenic Shock Working Group Registry — Recruiting now
• First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma — Running, not enrolling
• Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies — Starting soon
• Add-on Reparixin in Adult Patients With ARDS — Completed
• NOURISH-T+: Promoting Healthy Eating and Exercise Behaviors — Running, not enrolling
• P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myeloma — Running, not enrolling
• A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme — Running, not enrolling
• Gut and Intratumoral Microbiome Effect on the Neoadjuvant Chemotherapy-induced Immunosurveillance in Triple Negative Breast Cancer — Completed
• A Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease With Mild to Moderate Aortic Stenosis (EVOID-AS) — Paused
• Choosing the Best Antibiotic to Protect Friendly Gut Bacteria During the Course of Stem Cell Transplant — Running, not enrolling
• Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant Transplant — Running, not enrolling
• A(B)VD Followed by Nivolumab as Frontline Therapy for Higher Risk Patients With Classical Hodgkin Lymphoma (HL) — Running, not enrolling
• Phase III Study Assessing the Efficacy and Safety of Pegcetacoplan in Patients With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis — Completed
• A Study of CLN-619 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors — Running, not enrolling
• Study of Pembrolizumab in Patients With Early-Stage NK/T-cell Lymphoma, Nasal Type — Running, not enrolling
• Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating Fields — Running, not enrolling
• Adherence and Outcome of Upper Airway Stimulation (UAS) for OSA International Registry — Status unconfirmed
• Heart Failure Optimization Study — Completed
• Escitalopram for Agitation in Alzheimer's Disease — Running, not enrolling
• Phase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic Cancer — Stopped early
• Clinical Application of Stem Cell Educator Therapy in Type 1 Diabetes — Status unconfirmed
• Study Evaluating Safety and Efficacy of UCART Targeting CS1 in Patients With Relapsed/Refractory Multiple Myeloma (MELANI-01) — Stopped early
• Sundt™ Carotid Shunt Retrospective Post Market Clinical Follow-up Study (PMCF) — Completed
• A Study to Evaluate Rapid Throughput Screening for Human COVID-19 Infection — Stopped early
• Testing a Culturally Adapted Telephone Genetic Counseling Intervention — Completed
• A Phase 2 Study of siG12D LODER in Combination With Chemotherapy in Patients With Locally Advanced Pancreatic Cancer — Status unconfirmed